帕金森症 - dystonia-2: 沙特阿拉伯的案例系列研究
Mohammed A Almuqbil1,2,3, Sadia Tabassum4, Osama Y Muthaffar5
1College of Medicine, King Saud bin Abdulaziz University for Health Sciences (KSAU-HS), Riyadh, Saudi Arabia.
Annals of clinical and translational neurology
|February 23, 2024
概括
帕金森症-静脉缩-2 (PKDYS2) 是一种可治疗的遗传疾病. 基因检测有助于诊断这种疾病,使得及时的临床决策能够获得更好的患者结果.
科学领域:
- 神经遗传学 神经遗传学
- 儿科神经学 儿科神经学
- 代谢障碍 代谢障碍 代谢障碍
背景情况:
- 帕金森症-静脉缩-2 (PKDYS2) 是一种自体逆向性疾病.
- 它是由SLC18A2基因中的致病变异引起的,该基因编码了囊泡单胺转运体2 (VMAT2).
- PKDYS2是一种可治疗的神经递质缺乏障碍.
研究的目的:
- 在患有PKDYS2.2的患者中报告一种新的病理变异.
- 描述PKDYS2.2患者独特的MRI发现.
- 强调基因测试在儿科发育迟缓评估中的重要性.
主要方法:
- 基因分析以确定SLC18A2.2.中的致病变体.
- 对表现出运动障碍和发育迟缓的患者进行临床评估.
- 大脑MRI用于评估结构异常.
主要成果:
- 在SLC18A2基因中发现了一种新的致病性双变异.
- 在背部脑干中观察正常对称信号强度,并在MRI脑部进行测试.
- 证明基因测试如何影响临床管理.
结论:
- 基因检测对于诊断PKDYS2和其他可治疗的遗传疾病至关重要.
- 通过基因检测进行早期诊断,可以改善临床决策和患者的治疗结果.
- 新型变体和成像发现有助于更好地了解PKDYS2.
更多相关视频
06:45Rating L-DOPA-Induced Dyskinesias in the Unilaterally 6-OHDA-Lesioned Rat Model of Parkinson's Disease
Published on: October 4, 2021
2.7K
10:41Implantation of Osmotic Pumps and Induction of Stress to Establish a Symptomatic, Pharmacological Mouse Model for DYT/PARK-ATP1A3 Dystonia
Published on: September 12, 2020
7.4K
相关概念视频
Parkinson's Disease: Treatment
268
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
268
Parkinson's Disease: Overview
546
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
546
REM Sleep Behavior Disorder
184
REM Sleep Behavior Disorder (RBD) is a sleep disorder characterized by the absence of muscle paralysis that normally occurs during the REM phase of sleep. This absence allows individuals to physically act out their dreams, which are often vivid and disturbing. Common behaviors exhibited during episodes include kicking, punching, and yelling. These actions can be dangerous, potentially leading to injuries for the person with RBD or their bed partner.
RBD is significantly associated with...
RBD is significantly associated with...
184
Restless Leg Syndrome and Night Terrors
177
Restless Leg Syndrome (RLS), also known as Willis-Ekbom disease, is a neurological disorder characterized by an uncontrollable urge to move the legs due to uncomfortable sensations. These sensations typically occur during periods of rest or inactivity, particularly when lying down or sitting, and can severely disrupt sleep.
The exact cause of RLS is not fully understood, but it is believed to involve dopamine, a neurotransmitter that helps regulate muscle movement. Imbalances in dopamine levels...
The exact cause of RLS is not fully understood, but it is believed to involve dopamine, a neurotransmitter that helps regulate muscle movement. Imbalances in dopamine levels...
177
